Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Meizhong Xu is active.

Publication


Featured researches published by Meizhong Xu.


Bioorganic & Medicinal Chemistry Letters | 2009

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.

David M. Burns; Yun-Long Li; Eric Shi; Chunhong He; Meizhong Xu; Jincong Zhuo; Colin Zhang; Ding-Quan Qian; Yanlong Li; Richard Wynn; Maryanne Covington; Kamna Katiyar; Cindy Marando; Jordan S. Fridman; Peggy Scherle; Steve Friedman; Brian Metcalf; Wenqing Yao

A serendipitous discovery that the metalloprotease binding profile of a novel class of 2-carboxamide-3-hydroxamic acid piperidines could be significantly attenuated by the modification of the unexplored P1 substituent enabled the design and synthesis of a novel 2-carboxamide-1-hydroxamic acid cyclohexyl scaffold core that exhibited excellent HER-2 potency and unprecedented MMP-selectivity that we believe would not have been possible via conventional P1 perturbations.


Archive | 2007

Imidazotriazines and imidazopyrimidines as kinase inhibitors

Jincong Zhuo; Meizhong Xu; Chunhong He; Colin Zhang; Ding-Quan Qian; David M. Burns; Yun-Long Li; Brian Metcalf; Wenqing Yao


Archive | 2005

Lactam compounds and their use as pharmaceuticals

Wenqing Yao; Chunhong He; David M. Burns; Jincong Zhuo; Meizhong Xu; Colin Zhang; Ding-Quan Qian; Brian Metcalf


Archive | 2005

N-substituted piperidines and their use as pharmaceuticals

Wenqing Yao; Meizhong Xu; Colin Zhang; Yanlong Li; Jincong Zhuo; Brian Metcalf


Archive | 2005

2-Methylprop anamides and their use as pharmaceuticals

Wenqing Yao; Colin Zhang; Jincong Zhuo; Meizhong Xu; Konstantinos Agrios; Brian Metcalf


Archive | 2007

Triazolotriazines as kinase inhibitors

Jincong Zhuo; Colin Zhang; Meizhong Xu; Ding-Quan Qian; Wenqing Yao; Ravi Kumar Jalluri


Archive | 2016

IMIDAZOPYRIDINES AND IMIDAZOPYRAZINES AS LSD1 INHIBITORS

Liangxing Wu; Leah C. Konkol; Neil Lajkiewicz; Liang Lu; Meizhong Xu; Wenqing Yao; Zhiyong Yu; Colin Zhang; Chunhong He


Archive | 2014

SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3

Wenqing Yao; Colin Zhang; Meizhong Xu; Jincong Zhuo; Chunhong He


Bioorganic & Medicinal Chemistry Letters | 2008

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosis.

Wenqing Yao; Jincong Zhuo; David M. Burns; Yun-Long Li; Ding-Quan Qian; Colin Zhang; Chunhong He; Meizhong Xu; Eric Shi; Yanlong Li; Cindy Marando; Maryanne Covington; Xiangdong Liu; Max Pan; Jordan S. Fridman; Peggy Scherle; Zelda R. Wasserman; Gregory Hollis; Kris Vaddi; Swamy Yeleswaram; Robert Newton; Steve Friedman; Brian Metcalf


Archive | 2013

Fused Pyrazoles as FGFR Inhibitors

Jincong Zhuo; Meizhong Xu; Ding-Quan Qian

Collaboration


Dive into the Meizhong Xu's collaboration.

Researchain Logo
Decentralizing Knowledge